Thomas Sabia
Corporate Officer/Principal presso QUINCE THERAPEUTICS, INC.
Profilo
Thomas Sabia is currently the Chief Commercial Officer at Quince Therapeutics, Inc. He previously held the same position at EryDel SpA from 2022 to 2023.
Mr. Sabia has an undergraduate degree and an MBA from Salisbury State University.
Posizioni attive di Thomas Sabia
| Società | Posizione | Inizio |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2023 |
Precedenti posizioni note di Thomas Sabia
| Società | Posizione | Fine |
|---|---|---|
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 01/10/2023 |
Formazione di Thomas Sabia
| Salisbury State University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
- Borsa valori
- Insiders
- Thomas Sabia
